Cargando…
Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice
PURPOSE: Gastrointestinal mucositis, commonly associated with diarrhea, is a dose-limiting toxicity of chemotherapy. The new benzamidine derivative CR3294 reduces tissue damage in animal models of intestinal inflammation. Thus, we tested whether CR3294 had the potential to prevent chemotherapy-induc...
Autores principales: | Letari, Ornella, Booth, Catherine, Bonazzi, Albino, Garofalo, Paolo, Makovec, Francesco, Rovati, Lucio C., Caselli, Gianfranco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926937/ https://www.ncbi.nlm.nih.gov/pubmed/20041326 http://dx.doi.org/10.1007/s00280-009-1224-1 |
Ejemplares similares
-
Pharmacological characterisation of CR6086, a potent prostaglandin E(2) receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug
por: Caselli, Gianfranco, et al.
Publicado: (2018) -
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain
por: Ferrari, Flora, et al.
Publicado: (2011) -
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models
por: Sala, Emanuele, et al.
Publicado: (2020) -
Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties
por: Puja, Giulia, et al.
Publicado: (2022) -
N
(2)-o-Tolylbenzamidine
por: Zhang, Li-Zeng, et al.
Publicado: (2008)